Article
Azole-resistant Aspergillus fumigatus as an emerging worldwide pathogen.
Microbiology and immunology - 1 Mar 2022
Rivelli Zea Sofia Marisel, Toyotome Takahito
Abstract excerpt
Aspergillus fumigatus, a ubiquitous pathogen, causes aspergillosis in humans, especially in immunodeficient patients. Azoles are frontline antifungal drugs for treating aspergillosis. The recent global emergence of azole resistance in A. fumigatus has become a serious problem worldwide. It has arisen through two routes: long-term azole medical therapy, called the patient route, and the use of azole fungicides in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
